Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
An intervention with personalized risk-reduction goals, health coaching, and nurse visits was offered to patients who were between the ages of 70 and 89 years and had at least two targeted risk factors for dementia.
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
ACP is urging all adults to get vaccinated as influenza season, holiday gatherings, and winter weather are here, along with the continued presence of COVID-19 and respiratory syncytial virus.
ACP's Executive Committee of the Board of Governors announces the Class of 2029 Governor-elect Designees
The Governor-elect Designees will start their terms as Governors-elect after ACP's Annual Business Meeting on April 20, 2024.